“Venom: The Last Dance” debuted at No. 1 at the box office but fell significantly short of expectations, opening to just $51 million across 4,125 North American theaters.
This figure is well below the projected $65 million and notably lower than the previous installments, which opened at $80 million in 2018 and $90 million in 2021.
Sony is trying to find the reason behind this underwhelming performance – the two cities most affected—New York City and Los Angeles—were the top markets for the film.

Despite the slow start in North America, The Last Dance found success internationally,
grossing $124 million overseas for a global total of $175 million.
With a production cost of $120 million, the film needs to maintain a strong box office presence to recoup its budget.
The series has not received critical acclaim, with the latest installment holding a 37% rating on Rotten Tomatoes and earning a “B-” on CinemaScore, the lowest in the trilogy.
The film has a rating of 6.2 out of 10 on IMDb.
Directed by Kelly Marcel and starring Tom Hardy as Eddie Brock and his symbiotic partner Venom, the film continues the antihero’s story as they evade threats from their respective worlds.
Currently playing in theaters and IMAX are films like Lupita Nyong’o’s The Wild Robot, Joker: Folie à Deux, The Forge and more.
- ‘Little High’ Finds Comedy and Heartbreak in One Nairobi Afternoon
- The Odyssey: Nolan’s IMAX Epic Finally Hits Screens
- Kenyan Film ‘Tides’ Set for August Premiere
- 10 African Films to Stream Free on YouTube in 2026
- ‘Spider-Man: Brand New Day’ Trailer Tops 1.1 Billion Views Worldwide

Uncut Radio





